Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
{{output}}
Background: There are no topical treatments that have been specifically developed and approved for moderate to severe Chronic Hand Eczema (CHE). Objective: ... ...
